Edition:
India

Minerva Neurosciences Q2 Earnings Per Share $0.75

Aug 3 (Reuters) - Minerva Neurosciences Inc ::MINERVA NEUROSCIENCES REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATES.Q2 EARNINGS PER SHARE $0.75.Q2 EARNINGS PER SHARE ESTIMATE $-0.29 -- REFINITIV IBES DATA.QTRLY COLLABORATIVE REVENUE $41.2 MILLION.QTRLY DILUTED EARNINGS PER SHARE...

Monday, 3 Aug 2020

Glycomimetics Reports Q2 Loss Per Share Of $0.32

July 31 (Reuters) - GlycoMimetics Inc ::GLYCOMIMETICS REPORTS HIGHLIGHTS AND FINANCIAL RESULTS FOR SECOND QUARTER 2020.GLYCOMIMETICS INC QTRLY LOSS PER SHARE $0.32.

Friday, 31 Jul 2020

VBI Vaccines Posts Q2 Loss Per Share Of $0.04

July 31 (Reuters) - VBI Vaccines Inc ::VBI VACCINES ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 REVENUE $200,000 VERSUS $600,000.Q2 REVENUE ESTIMATE $635,000 -- REFINITIV IBES DATA.Q2 LOSS PER SHARE $0.04.Q2 EARNINGS PER SHARE ESTIMATE $-0.04 -- REFINITIV IBES...

Friday, 31 Jul 2020

Unity Biotechnology Reporst Qtrly Loss Per Share $0.38

July 31 (Reuters) - UNITY Biotechnology Inc ::UNITY BIOTECHNOLOGY, INC. REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND CLINICAL PROGRAM UPDATES.UNITY BIOTECHNOLOGY INC - BELIEVES CURRENT CASH RESOURCES ARE SUFFICIENT TO FUND OPERATIONS INTO H2 2021.UNITY BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE...

Friday, 31 Jul 2020

Expansion & New Markets

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.